Delivery Order SPE2DB24D2216-SPE2DB25FGNSW
Award Date
5/22/25
Potential Completion Date
5/23/25
Potential Value
$5.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $6,656.55 firm fixed-price delivery order is for the supply of 4,567,693,618 units of the 30 mg capsule of the medication Vyvanse. The contract has an ultimate completion date of March 26, 2025 and was awarded on March 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract, valued at $4,047.26, is a Firm Fixed Price Delivery Order for the provision of 100 capsules of the prescription medication Vyvanse 10 mg. The contract has an ultimate completion date of March 5, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The specific award is for $5,194.82 to provide 4,563,087,245 units of the pharmaceutical product Vyvanse 20 mg capsules. This delivery order has a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,289.84 firm fixed-price delivery order is for the supply of 4,568,142,307 units of the 30 mg Vyvanse capsule medication. The contract has an ultimate completion date of May 6, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,537.27 firm fixed-price delivery order is for the supply of Vyvanse 50 mg capsules, a prescription medication. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. This appears to be a task order under a larger Indefinite Delivery Contract (IDC) that...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,520.16 firm fixed-price delivery order contract is for the supply of 4,567,966,177 units of the drug Vyvanse 20 mg capsules. The contract has an ultimate completion date of April 15, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,006.66, is a delivery order for the supply of 4,567,264,038 units of the prescription drug Vyvanse 30 mg capsules. The contract has an ultimate completion date of February 14, 2025 and uses a firm fixed price pricing type. This award is part of a larger Indefinite Delivery Contract (IDC) that...
This federal contract award was made by the Defense Logistics Agency (DLA), a defense agency, to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,614.56 firm fixed-price delivery order is for the supply of 4,568,164,860 units of the prescription medication Vyvanse 50 mg capsules. The contract has a performance period extending to May 7, 2025. This award is not associated with a set-aside designation, indicating open competition....
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,868.93 firm fixed-price delivery order is for the supply of 4,565,639,987 Vyvanse 30 mg capsules. The contract has an ultimate completion date of August 30, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,175.84 firm-fixed-price delivery order is for the supply of 4,567,792,307 units of the prescription drug Vyvanse 10 mg capsules. The contract has an ultimate completion date of April 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...